Kimberly-Clark Corporation (KMB)
Slow GrowerFairStock Score: 57/100 — STEADY
Key Financials
| Current Price | $95.91 |
| Market Cap | $34.1B |
| P/E Ratio | 18.55 |
| ROE | 111.73% |
| Dividend Yield | 5.17% |
| Sector | Consumer Defensive |
Strengths
- Fortress moat in essential consumer staples with strong brand recognition across diapers, feminine care, and tissue categories
- Robust free cash flow generation of $912.9M providing resilience during economic downturns
- Low business volatility with beta of 0.23, offering portfolio stability and defensive characteristics
- Consistent Q4 2025 performance with 12.23% net margin demonstrating operational execution
- Market leadership positions providing pricing power in inelastic demand categories
Concerns
- Extreme valuation with EV/EBITDA of 59.48 and negative 732% margin of safety at Graham Number
- Excessive leverage with D/E ratio of 4.65 limiting financial flexibility and increasing refinancing risk
- Deteriorating financial quality signals from Piotroski F-Score of 5/9 warrant deeper investigation
- Minimal free cash flow yield of 1.7% provides inadequate return for capital deployed at current prices
AI Analysis
Kimberly-Clark presents a classic defensive business with genuine competitive advantages, yet the valuation demands scrutiny. The company operates in essential consumer categories—diapers, feminine care, tissue—where brand loyalty and distribution networks create a meaningful moat. With $912.9M in free cash flow and a low beta of 0.23, this is a genuinely stable enterprise. However, I'm troubled by several red flags that give me pause. The EV/EBITDA ratio of 59.48 is egregiously high—I've seen better valuations on growth stocks. The Graham Number of $12.36 versus the current price of $102.85 reveals a staggering 732% margin of safety deficit. This isn't a margin of safety; it's a margin of danger. The Piotroski F-Score of 5/9 suggests deteriorating financial quality, and the Altman Z-Score of 2.32 sits in the warning zone. More concerning is the debt-to-equity ratio of 4.65—excessive leverage for a mature business with modest growth prospects. The ROE of 126.6% appears artificially inflated due to negative equity from buybacks and dividends, not genuine operational excellence. At current prices, I'm paying a substantial premium for stable but uninspiring returns. The company's ability to generate cash is genuine, but shareholders are getting little margin of safety for their capital. This is a business I respect operationally but cannot recommend at these valuations.
Bull Case
Kimberly-Clark's essential product categories ensure recession-resistant demand, and management's pricing power enables margin expansion despite inflation. The fortress balance sheet, while leveraged, continues generating substantial free cash flow supporting the dividend, making this an ideal retirement portfolio holding for income-focused investors.
Bear Case
At 59x EV/EBITDA, the market has priced in perfection for a low-growth, mature business. Mounting consumer pressure from private-label competitors, coupled with excessive debt levels and deteriorating operational metrics, suggests significant downside risk if growth disappoints or interest rates remain elevated.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer